Alphabet NASDAQ: GOOGL has staged an impressive recovery in recent months, bouncing more than 23% from its 52-week low in April and now down just 8% year-to-date. While the tech giant still trails many of its Magnificent Seven peers, the tide is slowly turning in its favor.

Halliburton teams up with Petronas to deploy next-gen modeling tools to speed up exploration, enhance accuracy and boost reservoir management.

CNQ will divest a 75% stake in Seiu Lake to finalize its Palliser Block deal, easing competition concerns in Alberta.

I rate iShares MSCI Europe Financials ETF a Buy, as recent performance and favorable equity factors suggest a good entry point compared to other European and U.S. financial ETFs. EUFN offers a 4% yield, solid dividend growth, and broad exposure to European financials, but comes with higher volatility and currency risk. WisdomTree Europe Hedged Equity Fund ETF provides currency-hedged, diversified European exposure, outperforming over the last decade, but EUFN has led in recent years except for short-term periods.

Coinbase Global (NASDAQ:COIN) experienced a surge of 16% during Wednesday's trading and has risen nearly 20% over the course of the past week. This increase follows the approval of the highly awaited stablecoin regulation bill by the Senate.

New pharmacokinetic and cardiac biomarker data further demonstrate ifetroban's potential to protect the heart and reduce cardiac damage in DMD patients NASHVILLE, Tenn. , June 23, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company committed to developing new products for rare diseases, shared the latest positive results from its Phase 2 FIGHT DMD trial evaluating ifetroban, a novel oral therapy for Duchenne muscular dystrophy (DMD) heart disease, at the annual Parent Project Muscular Dystrophy (PPMD) conference in Las Vegas.

IRVING, Texas , June 23, 2025 /PRNewswire/ -- Caterpillar Inc. (NYSE: CAT) will host its 2025 Investor Day Nov. 4, in the Dallas area, beginning at 9:00 a.m. CST. Chief Executive Officer Joe Creed and the Caterpillar executive leadership team will provide an update on strategic priorities and growth opportunities as the company embarks on the next 100 years.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

One of the long-running hallmarks of the ETF industry is democratization of access to previously hard-to-reach asset classes. This includes private credit and equity and the broader alternative income space.

Bitcoin bettors got an early Christmas when it hit the six-figure mark in the first week of December 2024. But its ongoing rise to another all-time high this year creates bullish momentum for the Direxion Daily Crypto Industry Bull 2X Shares (LMBO).

The Lennox Side Discharge Heat Pump is a compact unit designed for efficient, quiet operation. DALLAS , June 23, 2025 /PRNewswire/ -- Lennox Residential HVAC, industry-leader in home comfort solutions, announced the launch of the Elite Series EL18KSLV Side Discharge Heat Pump, combining efficient performance and space-saving design.

Super Micro Computer is evolving into a global AI infrastructure leader, driven by first-to-market Nvidia Blackwell deployments in Europe and a $20 billion Saudi DataVolt partnership. The stock's valuation is attractive for investment, given a strong secular growth horizon. 2026 macroeconomic bull-market conditions could be the key catalyst to refresh sentiment. The Taiwan-China issue continues to linger, but the best security for the market rests not in fear but in proactive engagement through diplomacy. The U.S. is starting to recognize this.

Wendy's (WEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Dive into cheap, tech-focused Zacks Rank #1 (Strong Buy) stocks trading for well under $20 a share that offer long-term upside in July and beyond.

The semiconductor supplier agreed with top creditors to exchange most of its debt for equity and file a near-term bankruptcy.

The risk appetite of traders will have taken a bit of a beating over the weekend, as the Americans have bombed the Iranians over the weekend. However, markets look to be stabilizing as we head towards the New York session.

Enrollment in company's first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25% As recently announced , initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expected Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's intestinal failure products, resulting in non-dilutive funding for Jaguar SAN FRANCISCO, CA / …

LOS ANGELES , June 23, 2025 /PRNewswire/ -- Cineverse Corp. (NASDAQ: CNVS), a next-generation entertainment studio, today announced it will release its financial results for the fourth quarter and full fiscal year 2025 ended March 31, 2025, after market close on Friday, June 27, 2025. Cineverse will host a conference call discussing these results at 9 a.m.

Novel Diabetes Gene Therapy Shows Potential for Re-Dosing Using Non-Viral Delivery System AUSTIN, Texas , June 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators presented positive preclinical data and research from studies of GPX-002, the Company's diabetes gene therapy drug candidate, at the 2025 American Diabetes Association (ADA) 85th Scientific Session in Chicago. These studies used an alternative second-generation approach with a non-viral lipid nanoparticle delivery system.

REDWOOD CITY, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to daraxonrasib, the company's RAS(ON) multi-selective inhibitor, for previously treated metastatic PDAC in patients with KRAS G12 mutations.